ARCTURUS THERAPEUTICS HOLDINGS INC. Increase (Decrease) in Prepaid Expense and Other Assets
ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.11 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$299.00K.
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$809.00K.
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$916.00K, a 159.75% decline year-over-year.
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $57.00K, a 93.29% decline year-over-year.
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$5.00M, a 303.75% decline from fiscal 2024.
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $2.46M.
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.17M, a 132.51% decline from fiscal 2022.
- ARCTURUS THERAPEUTICS HOLDINGS INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $3.58M, a 53.62% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$299.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.11M 10-Q · filed 2026-08-06 | -$2.02M derived: sum of 3 quarters · filed 2026-08-06 | -$1.97M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$809.00K 10-Q · filed 2026-05-07 | -$1.73M derived: sum of 2 quarters · filed 2026-05-07 | -$1.67M derived: sum of 3 quarters · filed 2026-05-07 | -$4.61M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$916.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$859.00K derived: sum of 2 quarters · filed 2026-03-03 | -$3.80M derived: sum of 3 quarters · filed 2026-08-06 | -$5.00M 10-K · filed 2026-03-03 |
| 2025-09-30 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.88M derived: sum of 2 quarters · filed 2026-08-06 | -$4.09M 10-Q · filed 2025-11-12 | -$2.56M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$2.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$4.14M 10-Q · filed 2026-08-06 | -$2.61M derived: sum of 3 quarters · filed 2026-08-06 | -$1.76M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.20M 10-Q · filed 2026-05-07 | $330.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.18M derived: sum of 3 quarters · filed 2026-05-07 | $3.44M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $2.38M derived: sum of 2 quarters · filed 2026-03-03 | $4.64M derived: sum of 3 quarters · filed 2026-03-03 | $2.46M 10-K · filed 2026-03-03 |
| 2024-09-30 | $850.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.11M derived: sum of 2 quarters · filed 2025-11-12 | $923.00K 10-Q · filed 2025-11-12 | $314.00K derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-06-30 | $2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $73.00K 10-Q · filed 2025-08-11 | -$536.00K derived: sum of 3 quarters · filed 2026-03-03 | $3.62M derived: sum of 4 quarters · filed 2026-03-03 |
| 2024-03-31 | -$2.19M 10-Q · filed 2025-05-12 | -$2.79M derived: sum of 2 quarters · filed 2026-03-03 | $1.36M derived: sum of 3 quarters · filed 2026-03-03 | $1.20M derived: sum of 4 quarters · filed 2026-03-03 |
| 2023-12-31 | -$609.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $3.55M derived: sum of 2 quarters · filed 2026-03-03 | $3.38M derived: sum of 3 quarters · filed 2026-03-03 | -$1.17M 10-K · filed 2026-03-03 |
| 2023-09-30 | $4.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.99M derived: sum of 2 quarters · filed 2024-11-07 | -$556.00K 10-Q · filed 2024-11-07 | $1.17M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-06-30 | -$163.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$4.71M 10-Q · filed 2024-08-05 | -$2.99M derived: sum of 3 quarters · filed 2025-03-06 | -$2.06M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-03-31 | -$4.55M 10-Q · filed 2024-05-08 | -$2.82M derived: sum of 2 quarters · filed 2025-03-06 | -$1.90M derived: sum of 3 quarters · filed 2025-03-06 | $501.00K derived: sum of 4 quarters · filed 2025-03-06 |
| 2022-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $2.65M derived: sum of 2 quarters · filed 2025-03-06 | $5.05M derived: sum of 3 quarters · filed 2025-03-06 | $3.58M 10-K · filed 2025-03-06 |
| 2022-09-30 | $925.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $3.32M derived: sum of 2 quarters · filed 2023-11-14 | $1.86M 10-Q · filed 2023-11-14 | $1.89M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-06-30 | $2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $933.00K 10-Q · filed 2023-08-07 | $964.00K derived: sum of 3 quarters · filed 2024-03-14 | $3.73M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-03-31 | -$1.47M 10-Q · filed 2023-05-09 | -$1.44M derived: sum of 2 quarters · filed 2024-03-14 | $1.33M derived: sum of 3 quarters · filed 2024-03-14 | $2.49M derived: sum of 4 quarters · filed 2024-03-14 |
| 2021-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $2.80M derived: sum of 2 quarters · filed 2024-03-14 | $3.95M derived: sum of 3 quarters · filed 2024-03-14 | $2.33M 10-K · filed 2024-03-14 |
| 2021-09-30 | $2.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.92M derived: sum of 2 quarters · filed 2022-11-09 | $2.30M 10-Q · filed 2022-11-09 | $441.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$468.00K 10-Q · filed 2022-08-09 | -$2.33M derived: sum of 3 quarters · filed 2022-08-09 | -$759.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$1.62M 10-Q · filed 2022-05-09 | -$3.48M derived: sum of 2 quarters · filed 2022-05-09 | -$1.91M derived: sum of 3 quarters · filed 2022-05-09 | -$787.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$291.00K derived: sum of 2 quarters · filed 2022-03-01 | $832.00K derived: sum of 3 quarters · filed 2022-03-01 | $2.01M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $2.69M derived: sum of 2 quarters · filed 2021-11-09 | $3.87M 10-Q · filed 2021-11-09 | $2.02M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $2.30M 10-Q · filed 2021-08-10 | $449.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.38M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $1.18M 10-Q · filed 2021-05-10 | -$674.00K derived: sum of 2 quarters · filed 2022-03-01 | $256.00K derived: sum of 3 quarters · filed 2022-03-01 | $1.01M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$923.00K derived: sum of 2 quarters · filed 2022-03-01 | -$171.00K derived: sum of 3 quarters · filed 2022-03-01 | $120.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | $930.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.68M derived: sum of 2 quarters · filed 2020-11-09 | $1.97M 10-Q · filed 2020-11-09 | $2.16M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $752.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.04M 10-Q · filed 2020-08-10 | $1.23M derived: sum of 3 quarters · filed 2021-03-01 | $1.27M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $291.00K 10-Q · filed 2020-05-08 | $481.00K derived: sum of 2 quarters · filed 2021-03-01 | $514.00K derived: sum of 3 quarters · filed 2021-03-01 | |
| 2018-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $223.00K derived: sum of 2 quarters · filed 2021-03-01 | -$421.00K 10-K · filed 2021-03-01 | |
| 2018-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$611.00K 10-Q · filed 2019-11-08 | ||
| 2018-06-30 | -$644.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |